PAVmed Reports Better-Than-Expected Q4 Performance in Earnings and Revenue
Wednesday, 27 March 2024, 04:53
PAVmed Earnings Report
PAVmed press release (PAVM): Q4 Non-GAAP EPS of -$1.33 beats by $0.47. Revenue of $1.05M (vs. $0.11M Y/Y) beats by $0.02M. PAVmed had cash and cash equivalents of $19.6 million.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.